Código QR (código de barras bidimensional)

A clinical observational study of dinutuximab beta as first-line maintenance treatment for patients with high-risk neuroblastoma in China

Abstract Background High-risk neuroblastoma (HR-NB) is associated with high metastatic and relapse rates that require intensive multimodal treatment. We evaluated the efficacy and safety of dinutuximab beta as first-line maintenance immunotherapy in pediatric patients with HR-NB in real-world clinic...

Fuld beskrivelse

Na minha lista:
Principais autores: Xuedi Yu, Suyi Kang, Junjie Ge, Jingfu Wang
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2025-03-01
Serier:BMC Pediatrics
Fag:
High-risk neuroblastoma
Dinutuximab beta
GD2-antibody immunotherapy
GM-CSF
First-line maintenance
Chemotherapy
Online adgang:https://doi.org/10.1186/s12887-025-05568-x
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker